Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -4.88-22.9339.0023.66644.34

What is the latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS is -4.88 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-4.88
Mar2024-22.93
Mar202339.00
Mar202223.66
Mar2021644.34

How is Core EBITDA Growth of BAFNA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -4.88
Negative
Mar2024 -22.93
Negative
Mar2023 39
64.84
Mar2022 23.66
-96.33
Mar2021 644.34 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹258.1 Cr 2.2% -8% 29.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,728.0 Cr -0.8% 7.4% 8.6% Stock Analytics
DIVIS LABORATORIES ₹167,236.0 Cr -1.5% 5.7% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,951.0 Cr -1.8% 8.8% 44.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,765.0 Cr -1.2% 9.2% 14.9% Stock Analytics
CIPLA ₹106,033.0 Cr -2.5% 0.1% -7.6% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

2.2%

-8%

29.7%

SENSEX

-3.8%

-2%

6.3%


You may also like the below Video Courses